• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nanoparticles decorated with viral antigens are more immunogenic at low surface density.用病毒抗原修饰的纳米颗粒在低表面密度下具有更高的免疫原性。
Vaccine. 2017 Feb 1;35(5):774-781. doi: 10.1016/j.vaccine.2016.12.049. Epub 2017 Jan 3.
2
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.用包裹在纳米颗粒中的Toll样受体配体辅助猿猴免疫缺陷病毒疫苗可诱导持续性抗体反应并增强对TRIM5α限制型猕猴的保护。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01844-16. Print 2017 Feb 15.
3
Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.在接种CD4受体结合位点被封闭的gp140的猕猴中,与针对HIV-1包膜的辅助性T细胞反应相关的增强、持久的B细胞和ADCC反应。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00811-17. Print 2017 Oct 1.
4
Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin.用编码流感病毒血凝素的DNA免疫的小鼠对病毒攻击的抗体形成细胞反应。
J Virol. 1995 Dec;69(12):7712-7. doi: 10.1128/JVI.69.12.7712-7717.1995.
5
Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.编码流感病毒血凝素的质粒DNA尽管产生抗体反应的能力有限,但仍可诱导Th1细胞并提供针对呼吸道感染的保护。
J Gen Virol. 2000 Jul;81(Pt 7):1737-45. doi: 10.1099/0022-1317-81-7-1737.
6
Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation.自组装流感纳米颗粒疫苗可驱动延长的生发中心活性和记忆 B 细胞成熟。
JCI Insight. 2020 May 21;5(10):136653. doi: 10.1172/jci.insight.136653.
7
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.小鼠对裂解的可溶性HIV-1包膜三聚体的抗体反应在特异性上受到高度限制。
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
8
Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.壳聚糖包被聚己内酯纳米粒系统的研制及其对流感的有效免疫作用。
Vaccine. 2011 Nov 8;29(48):9026-37. doi: 10.1016/j.vaccine.2011.09.033. Epub 2011 Sep 20.
9
Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.一种多阴离子型 Carbomer 诱导针对 HIV-1 gp140 和流感病毒 HA 的强烈适应性免疫应答。
Vaccine. 2010 Mar 16;28(13):2482-9. doi: 10.1016/j.vaccine.2010.01.046. Epub 2010 Feb 2.
10
Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.通过密码子优化的HA DNA疫苗研究发现,甲型流感病毒H1和H3血清型的血凝素(HA)蛋白诱导最佳保护性抗体反应需要不同的抗原设计。
J Virol. 2006 Dec;80(23):11628-37. doi: 10.1128/JVI.01065-06. Epub 2006 Sep 20.

引用本文的文献

1
Precision Nanovaccines for Potent Vaccination.用于高效接种的精准纳米疫苗。
JACS Au. 2024 Jul 31;4(8):2792-2810. doi: 10.1021/jacsau.4c00568. eCollection 2024 Aug 26.
2
Development of Self-Assembled Protein Nanocage Spatially Functionalized with HA Stalk as a Broadly Cross-Reactive Influenza Vaccine Platform.基于空间功能化 HA 茎的自组装蛋白纳米笼的开发作为一种广谱交叉反应性流感疫苗平台。
ACS Nano. 2023 Dec 26;17(24):25045-25060. doi: 10.1021/acsnano.3c07669. Epub 2023 Dec 12.
3
Modeling the kinetics of lymph node retention and exposure of a cargo protein delivered by biotin-functionalized nanoparticles.通过生物素功能化纳米颗粒递送来模拟货物蛋白在淋巴结中的保留和暴露的动力学。
Acta Biomater. 2023 Oct 15;170:453-463. doi: 10.1016/j.actbio.2023.08.048. Epub 2023 Aug 29.
4
Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine.通过淋巴节点靶向疟疾传播阻断纳米疫苗实现免疫增强。
Front Immunol. 2021 Aug 27;12:729086. doi: 10.3389/fimmu.2021.729086. eCollection 2021.
5
Leveraging the modularity of biomaterial carriers to tune immune responses.利用生物材料载体的模块化来调节免疫反应。
Adv Funct Mater. 2020 Nov 25;30(48). doi: 10.1002/adfm.202004119. Epub 2020 Sep 11.
6
Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity.血凝素功能化脂质体疫苗增强生发中心和滤泡辅助性T细胞免疫。
Adv Healthc Mater. 2021 May;10(10):e2002142. doi: 10.1002/adhm.202002142. Epub 2021 Mar 9.
7
Nano-based approaches in the development of antiviral agents and vaccines.基于纳米的抗病毒药物和疫苗的研发方法。
Life Sci. 2021 Jan 15;265:118761. doi: 10.1016/j.lfs.2020.118761. Epub 2020 Nov 12.
8
Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines.基于衣壳样颗粒疫苗的标签/捕获介导的抗原展示的优势和前景。
Viruses. 2020 Feb 6;12(2):185. doi: 10.3390/v12020185.
9
A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.通过季节性流感建立的记忆 CD4 T 细胞动员克服禽流感疫苗免疫原性差的新型疫苗策略。
J Immunol. 2019 Sep 15;203(6):1502-1508. doi: 10.4049/jimmunol.1900819. Epub 2019 Aug 9.
10
Protein Vaccination Directs the CD4 T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.蛋白疫苗接种使 CD4 T 细胞应答偏向于共享的保护性表位,这些表位在流感病毒感染后可以被回忆起来。
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00947-19. Print 2019 Oct 15.

本文引用的文献

1
Approaches to preventative and therapeutic HIV vaccines.预防和治疗性HIV疫苗的方法。
Curr Opin Virol. 2016 Apr;17:104-109. doi: 10.1016/j.coviro.2016.02.010. Epub 2016 Mar 15.
2
Shape and size-dependent immune response to antigen-carrying nanoparticles.形状和大小依赖性的抗原载体纳米颗粒的免疫反应。
J Control Release. 2015 Dec 28;220(Pt A):141-148. doi: 10.1016/j.jconrel.2015.09.069. Epub 2015 Oct 3.
3
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.在铁蛋白纳米颗粒上呈现类似天然的HIV-1包膜三聚体可提高其免疫原性。
Retrovirology. 2015 Sep 26;12:82. doi: 10.1186/s12977-015-0210-4.
4
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.血凝素茎纳米颗粒产生异源型流感保护。
Nat Med. 2015 Sep;21(9):1065-70. doi: 10.1038/nm.3927. Epub 2015 Aug 24.
5
Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo.抗原呈递动力学在体内控制T细胞/树突状细胞相互作用以及滤泡辅助性T细胞的生成。
Elife. 2015 Aug 10;4:e06994. doi: 10.7554/eLife.06994.
6
Advances in the development of influenza virus vaccines.流感病毒疫苗研发进展。
Nat Rev Drug Discov. 2015 Mar;14(3):167-82. doi: 10.1038/nrd4529.
7
Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure.稳定的、未裂解的HIV-1包膜糖蛋白gp140形成具有天然样结构的紧密折叠三聚体。
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18542-7. doi: 10.1073/pnas.1422269112. Epub 2014 Dec 15.
8
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.在使用点混合 MF59 佐剂的情况下,对禽流感 A/H7N9 疫苗的血清学反应:一项随机临床试验。
JAMA. 2014 Oct 8;312(14):1409-19. doi: 10.1001/jama.2014.12854.
9
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.玩捉迷藏:流感病毒血凝素的糖基化如何调节感染后的免疫反应。
Viruses. 2014 Mar 14;6(3):1294-316. doi: 10.3390/v6031294.
10
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.

用病毒抗原修饰的纳米颗粒在低表面密度下具有更高的免疫原性。

Nanoparticles decorated with viral antigens are more immunogenic at low surface density.

作者信息

Brewer Matthew G, DiPiazza Anthony, Acklin Joshua, Feng Changyong, Sant Andrea J, Dewhurst Stephen

机构信息

Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, United States.

Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, United States; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642, United States.

出版信息

Vaccine. 2017 Feb 1;35(5):774-781. doi: 10.1016/j.vaccine.2016.12.049. Epub 2017 Jan 3.

DOI:10.1016/j.vaccine.2016.12.049
PMID:28057386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5876043/
Abstract

There is an urgent need to develop protective vaccines for high priority viral pathogens. One approach known to enhance immune responses to viral proteins is to display them on a nanoparticle (NP) scaffold. However, little is known about the effect of protein density on the B cell response to antigens displayed on NPs. To address this question HIV-1 Envelope (Env) and influenza hemagglutinin (HA) were displayed on a polystyrene-based NP scaffold at various densities - corresponding to mean antigen distances that span the range encountered on naturally occurring virions. Our studies revealed that NPs displaying lower densities of Env or HA more efficiently stimulated antigen-specific B cells in vitro, as measured by calcium flux, than did NPs displaying higher antigen densities. Similarly, NPs displaying a low density of Env or HA also elicited higher titers of antigen-specific serum IgG in immunized BALB/c mice (including elevated titers of hemagglutination-inhibiting antibodies), as well as an increased frequency of antigen-specific antibody secreting cells in the lymph node, spleen and bone marrow. Importantly, our studies showed that the enhanced B cell response elicited by the lower density NPs is likely secondary to more efficient development of follicular helper CD4 T cells and germinal center B cells. These findings demonstrate that the density of antigen on a NP scaffold is a critical determinant of the humoral immune response elicited, and that high density display does not always result in an optimal response.

摘要

迫切需要为高优先级病毒病原体开发保护性疫苗。一种已知可增强对病毒蛋白免疫反应的方法是将它们展示在纳米颗粒(NP)支架上。然而,关于蛋白密度对NP上展示的抗原的B细胞反应的影响知之甚少。为了解决这个问题,HIV-1包膜(Env)和流感血凝素(HA)以各种密度展示在基于聚苯乙烯的NP支架上,这些密度对应于天然病毒体上遇到的平均抗原距离范围。我们的研究表明,通过钙流测量,展示较低密度Env或HA的NP在体外比展示较高抗原密度的NP更有效地刺激抗原特异性B细胞。同样,展示低密度Env或HA的NP在免疫的BALB/c小鼠中也引发了更高滴度的抗原特异性血清IgG(包括血凝抑制抗体滴度升高),以及淋巴结、脾脏和骨髓中抗原特异性抗体分泌细胞的频率增加。重要的是,我们的研究表明,较低密度NP引发的增强B细胞反应可能继发于滤泡辅助性CD4 T细胞和生发中心B细胞更有效的发育。这些发现表明,NP支架上抗原的密度是引发体液免疫反应的关键决定因素,并且高密度展示并不总是导致最佳反应。